Get the Stockscreener App
1.0496
0.98%
-0.0104
Neuroone Medical Technologies Corp stock is traded at $1.0496, with a volume of 158.61K.
It is down -0.98% in the last 24 hours and down -28.11% over the past month.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.
See More
Previous Close:
$1.06
Open:
$1.05
24h Volume:
158.61K
Relative Volume:
0.73
Market Cap:
$9.56M
Revenue:
$9.19M
Net Income/Loss:
$-6.94M
P/E Ratio:
-1.262
EPS:
-0.8317
Net Cash Flow:
$-7.57M
1W Performance:
-2.81%
1M Performance:
-28.11%
6M Performance:
-76.36%
1Y Performance:
-80.56%
1-Day Range:
$1.01
$1.09
1-Week Range:
$1.04
$1.14
52-Week Range:
$0.9615
$6.12
Neuroone Medical Technologies Corp Stock (NMTC) Company Profile
Name
Neuroone Medical Technologies Corp
Sector
Industry
Phone
(952) 426-1383
Address
7599 ANAGRAM DR, EDEN PRAIRIE
Compare NMTC vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NMTC
Neuroone Medical Technologies Corp
|
1.0496 | 9.56M | 9.19M | -6.94M | -7.57M | -0.8317 |
ABT
Abbott Laboratories
|
104.47 | 180.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.28 | 121.88B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
291.70 | 111.89B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
43.77 | 63.43B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.59 | 49.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuroone Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-05-25 | Initiated | Ladenburg Thalmann | Buy |
| Mar-29-22 | Downgrade | Craig Hallum | Buy → Hold |
Neuroone Medical Technologies Corp Stock (NMTC) Latest News
Saba Capital Income & Opportunities Fund II (SABA) Stock Price, News, Quote & History - Yahoo! Finance Canada
OneMedNet Corporation Announces 1-for-10 Reverse Stock Split - Yahoo Finance
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com
NeuroOne at Moody Capital conference: thin-film platform aims for growth - Investing.com UK
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Australia
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com Nigeria
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com India
NeuroOne CBO David Wambeke buys $66,999 in company stock - Investing.com
NeuroOne Medical (NMTC) exec buys shares and receives 35,000 options - Stock Titan
NeuroOne CBO David Wambeke buys $66,999 in company stock By Investing.com - Investing.com South Africa
BioRestorative Therapies Announces Reverse Stock Split - Yahoo Finance
NeuroOne (NMTC) CFO gets 35,000 options at $1.77 - Stock Titan
NeuroOne (NMTC) grants officer options at $1.77 - Stock Titan
Neuroone Medical Technologies Corp (NASDAQ: NMTC) Stock Price, News & Analysis - kalkine.ca
NeuroOne Medical (NMTC) grants CTO 15,000 options vesting from 2027 - Stock Titan
NeuroOne Medical (NMTC) CEO granted 68K stock options - Stock Titan
NeuroOne Medical (NMTC) CAO awarded 12,500 stock options - Stock Titan
NeuroOne Medical | 4: Statement of changes in beneficial ownership of securities-Officer Rosa David A - Moomoo
Neuroone Medical Technologies Corp (NMTC) Key Financial Ratios – Valuation, Profitability & More - Value Research
NeuroOne Expects First StereoCED Revenue in Current Quarter - minichart.com.sg
NeuroOne reports successful large-animal StereoCED procedures, expects related revenue in Q4 2026 - TradingView
NeuroOne Announces Successful Robotic-Assisted Drug Delivery Using Next-Generation StereoCED(TM) Platform - Yahoo Finance
NeuroOne (NMTC) Q3 2026 Earnings Call Transcript - The Globe and Mail
JonesTrading Maintains NeuroOne Medical(NMTC.US) With Buy Rating, Maintains Target Price $8 - Moomoo
NeuroOne Medical Technologies (NasdaqCM:NMTC) Stock Forecast & Analyst Predictions - Simply Wall Street
NeuroOne Medical Technologies Corp (NMTC) (Q3 2026) Earnings Cal - GuruFocus
Neuroone Medical earnings missed by $0.10, revenue fell short of estimates - Investing.com
NMTC Maintained by Maxim Group -- Price Target Lowered to $5.00 - GuruFocus
NeuroOne (NMTC) Earnings Call zum 3. Quartal des Geschäftsjahres 2026: Aufträge steigen um 43 %, Marge erreicht 59,9 % - TradingKey
Nerdy Inc. Announces 1-For-15 Reverse Stock Split - Yahoo Finance
NeuroOne Medical Technologies Corporation Q3 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: NeuroOne Medical posts Q3 2026 revenue growth as shares fall - Investing.com
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Australia
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Nigeria
Is NeuroOne Medical Technologies Corp (NMTC) Positioned for Grow - GuruFocus
NEUROONE MEDICAL TECHNOLOGIES Corp 3Q FY2026: Revenue $1.97M, EPS $(0.28) — 10-Q Summary - TradingView
Q3 2026 NeuroOne Medical Technologies Corp Earnings Call Transcript - GuruFocus
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com Canada
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com India
Form 8K Neuroone Medical Technologies Corp For: 13 August By Investing.com - Investing.com UK
NeuroOne posts Q3 FY2026 revenue up 16% to $2.0M; gross margin expands to 59.9% - TradingView
NeuroOne Medical Technologies (NASDAQ: NMTC) posts larger loss and flags going concern risk - Stock Titan
NeuroOne Fiscal Q3 2026 Earnings: Gross Margin Expands as Net Loss Widens - TradingKey
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - Yahoo Finance
NeuroOne(R) Reports Fiscal Q3 2026 Financial Results, Revenues Increase 16% YoY to $2.0 Million; Gross Margins Expand to 59.9% - The Globe and Mail
NeuroOne(R) Achieves Major Milestone With ISO 13485 Certification - Yahoo Finance
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
NeuroOne(R) to Report Third Quarter Fiscal Year 2026 Financial Results on Thursday, August 13, 2026, at 8:30 a.m. Eastern Time - finance.yahoo.com
Neuroone Medical Technologies Corp Stock (NMTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neuroone Medical Technologies Corp Stock (NMTC) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Christianson Mark | Market Development Director |
Jun 30 '26 |
Sale |
3.18 |
10,000 |
31,773 |
20,692 |
| Christianson Mark | Officer |
Jun 30 '26 |
Proposed Sale |
3.34 |
10,000 |
33,400 |
0 |
| Christianson Mark | Business Development Director |
Mar 30 '26 |
Sale |
0.74 |
15,363 |
11,369 |
198,920 |
| Christianson Mark | Business Development Director |
Mar 13 '26 |
Sale |
0.80 |
100 |
80 |
214,283 |
| Christianson Mark | Business Development Director |
Mar 12 '26 |
Sale |
0.80 |
817 |
654 |
214,383 |
| Christianson Mark | Business Development Director |
Mar 11 '26 |
Sale |
0.80 |
2,109 |
1,687 |
215,200 |
| Christianson Mark | Business Development Director |
Mar 10 '26 |
Sale |
0.80 |
11,611 |
9,289 |
217,309 |
| Christianson Mark | Officer |
Mar 09 '26 |
Proposed Sale |
0.84 |
30,000 |
25,200 |
0 |
| Wambeke David J. | Chief Business Officer |
Mar 01 '26 |
Buy |
0.67 |
1,000,000 |
670,400 |
1,000,000 |
0.00%
3.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):